Found: 38
Select item for more details and to access through your institution.
Correction to "Patient perspectives and experiences with basal insulin titration in type 2 diabetes in the United States: A cross‐sectional survey".
- Published in:
- 2023
- Publication type:
- Correction Notice
A 1‐year pilot study of intralymphatic injections of GAD‐alum in individuals with latent autoimmune diabetes in adults (LADA) with signs of high immunity: No safety concerns and resemblance to juvenile type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3400, doi. 10.1111/dom.15239
- By:
- Publication type:
- Article
Prevalence of obesity and associated complications in China: A cross‐sectional, real‐world study in 15.8 million adults.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3390, doi. 10.1111/dom.15238
- By:
- Publication type:
- Article
Efficacy of anti‐CD3 monoclonal antibodies in delaying the progression of recent‐onset type 1 diabetes mellitus: A systematic review, meta‐analyses and meta‐regression.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3377, doi. 10.1111/dom.15237
- By:
- Publication type:
- Article
The rest‐activity rhythm, genetic susceptibility and risk of type 2 diabetes: A prospective study in UK Biobank.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3366, doi. 10.1111/dom.15236
- By:
- Publication type:
- Article
Development of a novel Fc fusion protein dual glucagon‐like peptide‐1 and gastric inhibitory polypeptide receptor agonists.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3356, doi. 10.1111/dom.15235
- By:
- Publication type:
- Article
Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3347, doi. 10.1111/dom.15234
- By:
- Publication type:
- Article
Remnant cholesterol, but not low‐density lipoprotein cholesterol, is associated with intra‐pancreatic fat deposition.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3337, doi. 10.1111/dom.15233
- By:
- Publication type:
- Article
Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3327, doi. 10.1111/dom.15232
- By:
- Publication type:
- Article
A J‐shaped relationship between ketones and the risk of diabetic kidney disease in patients with type 2 diabetes: New insights from a cross‐sectional study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3317, doi. 10.1111/dom.15231
- By:
- Publication type:
- Article
Glucose‐lowering drug use in migrants and native Danes with type 2 diabetes: Disparities in combination therapy and drug types.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3307, doi. 10.1111/dom.15230
- By:
- Publication type:
- Article
Initial antibiotic therapy for postoperative moderate or severe diabetic foot infections: Broad versus narrow spectrum, empirical versus targeted.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3290, doi. 10.1111/dom.15228
- By:
- Publication type:
- Article
Labisia pumila standardized extract (SKF7®) reduces percentage of waist circumference and waist‐to‐height ratio in individuals with obesity.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3298, doi. 10.1111/dom.15229
- By:
- Publication type:
- Article
Comparative efficacy of digitally assisted interventions for glycated haemoglobin levels among patients with type 2 diabetes: A systematic review and component network Meta‐Analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3279, doi. 10.1111/dom.15227
- By:
- Publication type:
- Article
Pharmacological activation of insulin‐degrading enzyme improves insulin secretion and glucose tolerance in diet‐induced obese mice.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3268, doi. 10.1111/dom.15225
- By:
- Publication type:
- Article
Associations of lipoprotein subclasses with risk of all‐cause and cardiovascular disease mortality in individuals with type 2 diabetes: A prospective cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3259, doi. 10.1111/dom.15224
- By:
- Publication type:
- Article
Impact of the COVID‐19 pandemic on new diagnoses of type 2 diabetes in England.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3424, doi. 10.1111/dom.15223
- By:
- Publication type:
- Article
In praise of pioglitazone: An economically efficacious therapy for type 2 diabetes and other manifestations of the metabolic syndrome.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3093, doi. 10.1111/dom.15222
- By:
- Publication type:
- Article
Safety of sodium‐glucose co‐transporter‐2 inhibitors on amputation across categories of baseline cardiovascular disease and diuretics use in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3248, doi. 10.1111/dom.15221
- By:
- Publication type:
- Article
The associations of sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors as add‐on to metformin with fracture risk in patients with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3235, doi. 10.1111/dom.15220
- By:
- Publication type:
- Article
Healthy lifestyle and all‐cause and cause‐specific dementia in individuals with type 2 diabetes and the roles of diabetes duration and insulin use in UK Biobank cohort.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3202, doi. 10.1111/dom.15215
- By:
- Publication type:
- Article
Baseline leptin predicts response to metformin in adolescents with type 1 diabetes and increased body mass index.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3420, doi. 10.1111/dom.15218
- By:
- Publication type:
- Article
Twelve‐month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed‐loop therapy outcomes versus conventional therapy in adults with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3212, doi. 10.1111/dom.15217
- By:
- Publication type:
- Article
The importance of glucose‐dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3079, doi. 10.1111/dom.15216
- By:
- Publication type:
- Article
Effects of once‐weekly glucagon‐like peptide‐1 receptor agonists on type 2 diabetes mellitus complicated with coronary artery disease: Potential role of the renin‐angiotensin system.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3223, doi. 10.1111/dom.15219
- By:
- Publication type:
- Article
Adipose tissue‐derived FABP4 mediates glucagon‐stimulated hepatic glucose production in gestational diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3192, doi. 10.1111/dom.15214
- By:
- Publication type:
- Article
Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow‐up study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3415, doi. 10.1111/dom.15213
- By:
- Publication type:
- Article
Testing for associations between HbA1c levels, polygenic risk and brain health in UK Biobank (N = 39 283).
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3136, doi. 10.1111/dom.15207
- By:
- Publication type:
- Article
Changes in the glycaemia risk index and its association with other continuous glucose monitoring metrics after initiation of an automated insulin delivery system in adults with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3144, doi. 10.1111/dom.15208
- By:
- Publication type:
- Article
Cysteine‐lowering treatment with mesna against obesity: Proof of concept and results from a human phase I, dose‐finding study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3161, doi. 10.1111/dom.15210
- By:
- Publication type:
- Article
Overall and inter‐individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3152, doi. 10.1111/dom.15209
- By:
- Publication type:
- Article
Fat‐to‐muscle ratio is associated with insulin resistance and cardiometabolic disorders in adults with type 1 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3181, doi. 10.1111/dom.15212
- By:
- Publication type:
- Article
A model‐based approach to predict individual weight loss with semaglutide in people with overweight or obesity.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3171, doi. 10.1111/dom.15211
- By:
- Publication type:
- Article
Relationship between the magnitude of body mass index reductions and remission in patients with type 2 diabetes in real world settings: Analysis of nationwide patient registry in Japan (JDDM74).
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3125, doi. 10.1111/dom.15206
- By:
- Publication type:
- Article
Hypoglycaemia induces a sustained pro‐inflammatory response in people with type 1 diabetes and healthy controls.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3114, doi. 10.1111/dom.15205
- By:
- Publication type:
- Article
Adaptive bolus calculators for people with type 1 diabetes: A systematic review.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3103, doi. 10.1111/dom.15204
- By:
- Publication type:
- Article
Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3410, doi. 10.1111/dom.15203
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3077, doi. 10.1111/dom.14758
- Publication type:
- Article